NCT05832112 (OTC-RATS) is a NA clinical trial of VATS/RATS lobectomy in Lung Cancer Stage I, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

Who is sponsoring NCT05832112?

NCT05832112 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

What drugs are being tested in NCT05832112?

Interventions in NCT05832112: VATS/RATS lobectomy.

What condition does NCT05832112 study?

NCT05832112 studies Lung Cancer Stage I.

Is NCT05832112 still recruiting?

NCT05832112 is currently active, enrolled. Last updated 18 March 2026.

Last reviewed 2026-03-18 · How we verify

NCT05832112: OTC-RATS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outside the Cage (OTC) Robotic Lobectomy

Active, enrolled NA Last updated 18 March 2026

What this trial tests

NA trial testing VATS/RATS lobectomy in Lung Cancer Stage I in 100 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

22 February 2023

Primary endpoint
9 December 2027

9 December 2028

Quick facts

Lead sponsor	Centre hospitalier de l'Université de Montréal (CHUM)
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	100
Start date	22 February 2023
Primary completion	9 December 2027
Estimated completion	9 December 2028
Sites	1 location across Canada

Drugs / interventions tested

VATS/RATS lobectomy

Conditions studied

Lung Cancer Stage I — all drugs for Lung Cancer Stage I →

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Who can join

18 and older, any sex, with Lung Cancer Stage I. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study consists in a prospective pilot study evaluating the feasibility and safety of OTC RATS lobectomies in patients treated for lung cancer. All patients with clinical stage I tumors (≤cT2N0M0) planned to undergo a VATS or RATS lobectomy at the CHUM will be approached. At our institution, lobectomies are either performed open by thoracotomy or by MIS, including VATS and RATS. The technique is selected based on tumor size, tumor location and patient characteristics. Only patients already planned for a VATS or RATS lobectomy will be approached. They will be identified through the operation request forms and will be approached either in the preoperative clinic or the day before surgery, when admitted. The investigators aim to recruit 20 patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Outside the Cage Subcostal RATS Lobectomy: Technical Aspects and Results of the First Series of a Novel Approach to Pulmonary Lobectomy.
Bulgarelli Maqueda L, Têtu M, Guimarães Rocha Lima P, Abu-Reida F, et al · · 2023 · cited 9× · PMID 38073258 · DOI 10.1177/15569845231217257
Feasibility and safety of outside the cage subcostal robotic anatomical lung resections: results of a phase I clinical trial.
Bulgarelli Maqueda L, Guimarães Rocha Lima P, Abu-Reida F, Alashgar O, et al · · 2025 · PMID 41522147 · DOI 10.21037/jtd-2025-1505

Verify or expand the search:

Other recruiting trials for Lung Cancer Stage I

Currently open trials in the same condition.

NCT06424327 — A Registry for People With Lung Cancer · recruiting
NCT05281237 — Avecure Flexible Microwave Ablation Probe For Lung Nodules · NA · recruiting

Other Centre hospitalier de l'Université de Montréal (CHUM) trials

Trials by the same sponsor.

NCT06735638 — Outside the Cage (OTC) Robotic Esophagectomy · Phase 1 · not yet recruiting
NCT07533253 — Rescue Distal Thrombectomy in Treatment for Persistent Distal Occlusions · NA · not yet recruiting
NCT05225272 — Effectiveness of an Enhanced Recovery After Surgery Protocol in Patients Undergoing On-pump Cardiac Surgery · not yet recruiting
NCT07497061 — Comparison of Two Surgical Techniques for the Treatment of Trigger Fingers: Longitudinal Opening Versus Complete A1 Pull · NA · not yet recruiting
NCT07196410 — KAN-004 for Immune-Related Diarrhea or Colitis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05832112 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM)
Last refreshed: 18 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05832112.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing